Attention Celerion eReg Portal Users:
We are experiencing technical issues with our eReg portal for mobile device users. Please login to the eReg portal using a desktop device to view study opportunities and details in your profile. Thank you for your patience and understanding.

 
 
 
 

CA46975-3A - 0x0000000000006923

Healthy Males & Females

Refresh

* Stipend may pay up to reflected amount.
Start Date: 
February 14, 2026 - 1:45pm
End Date: 
March 2, 2026 - 8:15am

Study Details

Study Number: CA46975
Group Number: 3A
Study Requirement: Healthy Normal Male and Female
Stipend: up to $5,500.00

Study Criteria

Age: 19 - 55
BMI: 18 - 32
Weight Restriction: minimum weight 0 lbs

Study Information

Indication: This investigational medication is being developed to treat of atopic dermatitis (AD).
Route of Administration: Oral
Blood Draws: 20

Study Schedule

Schedule Type: Long Term
Study Length: 9 Night Stay & 1 Return

Screening Dates:

Event Day Event Date
Thursday 2/5/2026
Thursday 2/5/2026
Thursday 2/12/2026
Thursday 2/12/2026
Friday 2/13/2026
Friday 2/13/2026
Saturday 2/14/2026
Saturday 2/14/2026

Doctor Exam Dates:

Event Day Event Date
Thursday 2/5/2026
Thursday 2/5/2026
Thursday 2/12/2026
Thursday 2/12/2026
Friday 2/13/2026
Friday 2/13/2026
Saturday 2/14/2026
Saturday 2/14/2026

Study Dates:

Event Type Start Day Start Date End Day End Date Phase Site
Check-In Saturday 2/14/2026 1:45:00 PM Monday 2/23/2026 8:30:00 AM 1 Lincoln
Check-In Saturday 2/14/2026 1:45:00 PM Monday 2/23/2026 8:30:00 AM 1 Lincoln
Return Monday 3/2/2026 7:15:00 AM Monday 3/2/2026 8:15:00 AM 1 Lincoln
Return Monday 3/2/2026 7:15:00 AM Monday 3/2/2026 8:15:00 AM 1 Lincoln